Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TIAL1P1 (TIAL1 cytotoxic granule-associated RNA binding protein-like 1 pseudogene) is a pseudogene related to the TIAL1 gene, which encodes an RNA-binding protein involved in RNA splicing, translational control, and apoptosis. As a pseudogene, TIAL1P1 does not produce a functional protein product and is not considered a therapeutic target. No known associated biological functions, disease roles, or drug interactions are established for this pseudogene, and it typically serves as a nonfunctional genomic sequence derived from its parent gene. No evidence supports a role as a biomarker or therapeutic target[2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TIAL1 cytotoxic granule-associated RNA binding protein-like 1 pseudogene (TIAL1P1).